Actively Recruiting

Phase Not Applicable
Age: 22Years - 80Years
All Genders
NCT04144972

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain

Led by University of California, San Francisco · Updated on 2025-07-08

12

Participants Needed

1

Research Sites

574 weeks

Total Duration

On this page

Sponsors

U

University of California, San Francisco

Lead Sponsor

N

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Chronic pain affects 1 in 4 US adults, and many cases are resistant to almost any treatment. Deep brain stimulation (DBS) holds promise as a new option for patients suffering from treatment-resistant chronic pain, but traditional approaches target only brain regions involved in one aspect of the pain experience and provide continuous 24/7 brain stimulation which may lose effect over time. By developing new technology that targets multiple, complimentary brain regions in an adaptive fashion, the investigators will test a new therapy for chronic pain that has potential for better, more enduring analgesia.

CONDITIONS

Official Title

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain

Who Can Participate

Age: 22Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 22-80 years old
  • Diagnosis of refractory chronic pain syndrome including post-traumatic pain, postsurgical pain, postherpetic neuralgia, complex regional pain syndrome, atypical facial pain, central pain syndromes, or post-radiation plexopathy
  • Severe pain lasting two or more years despite medical treatment
  • Average daily pain greater than 6 on a 0-10 numeric rating scale for the past 30 days
  • Pain fluctuates by at least 3 points on the numeric rating scale
  • Failure of at least two pain medications from different classes with stable doses for 30 days before baseline
  • No surgically correctable cause of pain as confirmed by two independent surgeons
  • Ability to read and speak English
  • Capable of understanding and providing informed consent
  • Montreal Cognitive Assessment score of 25 or higher indicating no significant cognitive impairment
  • Successful detection of pain biomarkers or positive response to inpatient stimulation trial if performed
Not Eligible

You will not qualify if you...

  • Major medical conditions increasing surgical risk such as uncontrolled hypertension, coagulopathy, severe diabetes, major organ failure, active infection, immunocompromise, or malignancy with less than 5 years life expectancy
  • Presence of incompatible implanted devices such as pacemakers, defibrillators, medication pumps, intracardiac lines, intracranial implants, or other stimulators not compatible with the study device
  • Pregnancy or breastfeeding; women of childbearing potential must have a negative pregnancy test before surgery
  • Active severe depression, recent suicide attempt within 12 months, imminent suicide risk, or untreated/uncontrolled psychiatric illness as determined by psychiatrist
  • History of substance abuse in the past 3 years
  • Inability to stop blood-thinning medications for surgery and recovery
  • Implantable hardware incompatible with MRI or study requirements
  • Brain MRI abnormalities suggesting alternative diagnosis or contraindicating surgery
  • Previous cranial ablative surgery
  • Previous DBS surgery using an incompatible system
  • Major neurological disorders other than those causing chronic pain, including epilepsy or neurodegenerative conditions
  • Need for diathermy, electroconvulsive therapy, or transcranial magnetic stimulation
  • Allergies or hypersensitivity to materials in the study device
  • Any condition judged by the principal investigator to increase risk or reduce benefit from DBS

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of California, San Francisco

San Francisco, California, United States, 94143

Actively Recruiting

Loading map...

Research Team

C

Catherine Borror

CONTACT

P

Prasad Shirvalkar, M.D., Ph.D

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here